Abstract | BACKGROUND:
Hyperhidrosis (primary or secondary) is excessive sweating beyond that required to return body temperature to normal. It can be localized or generalized, commonly affecting the axillae, palms, soles or face, and can have a substantial negative effect on a patient's quality of life. IMPACT OF DISEASE: Objective evaluation comprising quantitative assessment (gravimetric and Minor's iodine starch test) and subjective evaluation (Dermatology Quality of Life Index and Hyperhidrosis Impact Questionnaire) allow accurate assessment of the impact of hyperhidrosis on patients. BOTULINUM TOXIN TYPE A: CONCLUSIONS:
|
Authors | N Lowe, A Campanati, I Bodokh, S Cliff, P Jaen, O Kreyden, M Naumann, A Offidani, J Vadoud, H Hamm |
Journal | The British journal of dermatology
(Br J Dermatol)
Vol. 151
Issue 6
Pg. 1115-22
(Dec 2004)
ISSN: 0007-0963 [Print] England |
PMID | 15606505
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Neuromuscular Agents
- Botulinum Toxins, Type A
|
Topics |
- Axilla
- Botulinum Toxins, Type A
(therapeutic use)
- Hand
- Humans
- Hyperhidrosis
(drug therapy)
- Neuromuscular Agents
(therapeutic use)
|